ArticlePDF Available

Abstract and Figures

Due to the high prevalence of viral infections having no specific treatment and the constant appearance of resistant viral strains, the development of novel antiviral agents is essential. The aim of this study was to evaluate the antiviral activity against bovine viral diarrhea virus, herpes simplex virus type 1 (HSV-1), poliovirus type 2 (PV-2) and vesicular stomatitis virus of organic (OE) and aqueous extracts (AE) from: Baccharis gaudichaudiana, B. spicata, Bidens subalternans, Pluchea sagittalis, Tagetes minuta and Tessaria absinthioides. A characterization of the antiviral activity of B. gaudichaudiana OE and AE and the bioassay-guided fractionation of the former and isolation of one active compound is also reported. The antiviral activity of the OE and AE of the selected plants was evaluated by reduction of the viral cytopathic effect. Active extracts were then assessed by plaque reduction assays. The antiviral activity of the most active extracts was characterized by evaluating their effect on the pretreatment, the virucidal activity and the effect on the adsorption or post-adsorption period of the viral cycle. The bioassay-guided fractionation of B. gaudichaudiana OE was carried out by column chromatography followed by semipreparative high performance liquid chromatography fractionation of the most active fraction and isolation of an active compound. The antiviral activity of this compound was also evaluated by plaque assay. B. gaudichaudiana and B. spicata OE were active against PV-2 and VSV. T. absinthioides OE was only active against PV-2. The corresponding three AE were active against HSV-1. B. gaudichaudiana extracts (OE and AE) were the most selective ones with selectivity index (SI) values of 10.9 (PV-2) and >117 (HSV-1). For this reason, both extracts of B. gaudichaudiana were selected to characterize their antiviral effects. Further bioassay-guided fractionation of B. gaudichaudiana OE led to an active fraction, FC (EC50=3.1 mug/ml; SI= 37.9), which showed antiviral activity during the first 4 h of the viral replication cycle of PV-2 and from which the flavonoid apigenin (EC50 = 12.2 +/- 3.3 muM) was isolated as a major compound. The results showed that, among the species studied, B. gaudichaudiana seemed to be the most promising species as a source of antiviral agents.
Content may be subject to copyright.
RES E AR C H Open Access
In vitro antiviral activity of plant extracts from
Asteraceae medicinal plants
María F Visintini Jaime
, Flavia Redko
, Liliana V Muschietti
, Rodolfo H Campos
, Virginia S Martino
and Lucia V Cavallaro
Background: Due to the high prevalence of viral infections having no specific treatment and the constant
appearance of resistant viral strains, the development of novel antiviral agents is essential. The aim of this study was
to evaluate the antiviral activity against bovine viral diarrhea virus, herpes simplex virus type 1 (HSV-1), poliovirus
type 2 (PV-2) and vesicular stomat itis virus of organic (OE) and aqueous extracts (AE) from: Baccharis
gaudichaudiana, B . spicata, Bidens subalternans, Pluchea sagittalis, Tagetes minuta and Tessaria absinthioides.A
characterization of the antiviral activity of B. gaudichaudiana OE and AE and the bioassay-guided fractionation of
the former and isolation of one active compound is also reported.
Methods: The antiviral activity of the OE and AE of the selected plants was evaluated by reduction of the viral
cytopathic effect. Active extracts were then assessed by plaque reduction assays. The antiviral activity of the most
active extracts was characterized by evaluating their effect on the pretreatment, the virucidal activity and the effect
on the adsorption or post-adsorption period of the viral cycle. The bioassay-guided fractionation of
B. gaudichaudiana OE was carried out by column chromatography followed by semipreparative high performance
liquid chromatography fractionation of the most active fraction and isolation of an active compound. The antiviral
activity of this compound was also evaluated by plaque assay.
Results: B. gaudichaudiana and B. spicata OE were active against PV-2 and VSV. T. absinthioides OE was only active
against PV-2. The corresponding three AE were active against HSV-1. B. gaudichaudiana extracts (OE and AE) were
the most selective ones with selectivity index (SI) values of 10.9 (PV-2) and >117 (HSV-1). For this reason, both
extracts of B. gaudichaudiana were selected to characterize their antiviral effects. Further bioassay-guided
fractionation of B. gaudichaudiana OE led to an active fraction, F
=3.1 μg/ml; SI= 37.9), which showed antiviral
activity during the first 4 h of the viral replication cycle of PV-2 and from which the flavonoid apigenin (EC
3.3 μM) was isolated as a major compound.
Conclusions: The results showed that, among the species studied, B. gaudichaudiana seemed to be the most
promising species as a source of antiviral agents.
Keywords: Asteraceae, Antiviral activity, Baccharis gaudichaudiana, Poliovirus, Herpes simplex virus, Apigenin
* Correspondence:
Cátedra de Virología, Facultad de Farmacia y Bioquímica, Universidad de
Buenos Aires, Junín 956, 4ºP, Ciudad de Buenos Aires, 1113, Argentina
Full list of author information is available at the end of the article
© 2013 Visintini Jaime et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the
Creative Commons Attribution License (, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
Visintini Jaime et al. Virology Journal 2013, 10:245
Antiviral drugs for diseases caused by herpesviruses, ret-
roviruses, orthomyxoviruses, hepatitis B virus and hepa-
titis C virus (HCV) are currently commercially available
[1]. However, due to the high prevalence of viral infec-
tions for which there are no specific treatment and the
constant appearance of new resistant viral strains, the
development of novel antiviral agents is essential.
Natural products have proved to be an important
source of lead molecules and many extracts and com-
pounds of plant origin with antiviral activity have been
reported [2].
The great diversity of plants growing in Argentina offers
interesting possibilities of finding novel antiviral com-
pounds from a natural origin. Asteraceae is the most nu-
merous and diverse plant family in our country and is
highly promising from a pharmacological perspective [3].
The aim of this study was to evaluate the antiviral activ-
ity against bovine viral diarrhea virus (BVDV), herpes
simplex virus type 1 (HSV-1), poliovirus type 2 (PV-2) and
vesicular stomatitis virus (VSV) of organic (OE) and aque-
ous extracts (AE) from: Baccharis gaudichaudiana, Bac
charis spicata, Bidens subalternans, Pluchea sagittalis,
Tagetes minuta and Tessaria absinthioides, all medicinal
plants belonging to the Asteraceae family (Table 1) in
which different compounds from diverse chemical groups
have been found.
The selection of the viruses was based on the clinical
importance of their infections, the type of the genome
and the strategies of viral replication. HSV-1, a DNA
virus, is responsible of viral infections that have in-
creased over the past decades [14] and the development
of the rapeutic agents has become necessary due to its
growing incidence and the appearance of drug-resistant
strains, especially in immunocompromised patients [15].
Poliovirus is an RNA virus that causes poliomyelitis for
which there are two commercially available vaccines.
Nevertheless, no complete eradication of this viral infe c-
tion has been achieved [16]. There is a need to find ef-
fective drugs to complete the eradication plan and to
control future outbreaks [17].
BVDV and VSV cause serious disease in livestock and
are responsible for major losses in cattle. Both are RNA
viruses but BVDV has a positive sense genome while
VSV has a negative one . Moreover, BVDV is also ac-
cepted as a surrogate virus model for identifying and
characterizing antiviral agents to be used against HCV
[18] and VSV has been extensively studied as a prototype
of non-segmented, negative-strand RNA viruses [19].
Besides the results of the antiviral screening, the prelim-
inary characterization of the antiviral effect of the most
active extracts is reported. In addition, the bioassay-
guided fractionation of B. gaudichaudiana organic extract,
altogether with the isolation of its major antiviral com-
pound is also described.
Antiviral activity against BVDV, HSV-1, PV-2 and VSV
Six Argentinean Asteraceaes were selected for this study.
Chemical, ethnopharmacological data and previously
reported antiviral studies are shown in Table 1. The anti-
viral activ ity of plant extracts against BVDV, HSV-1,
PV-2 and VSV was assessed in vitro by the viral CPE reduc-
tion assay. Results obtained from this screening (Table 2)
showed that B. gaudichaudiana and B. spicata OE were
active against PV-2 and VSV, the AE of both species and
Table 1 Ethnopharmacological and chemical data of the medicinal plants selected
Plant species Vernacular
Place of
Popular use Chemical composition
Rosario, Santa
Fe, Argentina
Digestive, hepatic, antidiabetic, antidiarrheal, antiseptic in
urinary and respiratory tract infections [4]
Flavonoids, clerodane
diterpenoids, phenolics,
hydroxycinnamic acids [5]
spicata (Lam.)
Rosario, Santa
Fe, Argentina
Medicinal [6] Diterpenoids [4]
subalternans DC
amor seco Ciudad de
Buenos Aires,
Ocular antiseptic, to treat aphthae and sore throat [7,8] Triterpenoids, steroids [4]
sagittalis (Lam.)
Zarate, Buenos
Stomachic, hepatic, choleretic, antispasmodic, digestive,
cholagogue, antipyretic, antitussive, antiseptic, for
stomachache, febrifuge, antiseptic, for venereal diseases [4,9]
Phenylpropanoids, flavonoids,
essential oils, polyphenols,
tannins, triterpenes [4]
minuta L.
chinchilla Ibicuy, Entre
Rios, Argentina
Digestive, antispasmodic, diuretic, antifungal, anthelminthic,
antiseptic, antitussive, pectoral, disinfectant, in urinary tract
infections [10]
Terpenoids, flavonoids, essential
oils [11
(Hook. & Arn.)
Hypocholesterolemic, balsamic, expectorant, for hepatitis and
renal insufficiency [4]
Sesquiterpenes, sulfur
compounds, flavonoids, essential
oils [13]
Visintini Jaime et al. Virology Journal 2013, 10:245 Page 2 of 10
the AE of T. absinthioides were active against HSV-1
and T. absinthioides OE was active only against PV-2.
None of the twelve extract s was active a gainst BVDV.
To confirm the inhibitory effect detected in the screen-
ing, we evaluated the antiviral activity of the positive ex-
tracts by the plaque reduction assay and the SIs were
determined (Table 3). Regarding the active extracts, the
thin layer chromatographic (TLC) profiles of the OE of
the two Baccharis species were very similar. Bands corre-
sponding to flavonoid aglycones and terpenoids were ob-
served after spraying with NPR and anisaldehyde/H
On the other hand, Tessaria absinthioides OE showed
strong bands corresponding to flavonoid glycosides and
only weak bands corresponding to terpenoids in the OE
and AE (Additional file 1).
B. gaudichaudiana OE and AE exhibited the highest
SI values against PV-2 (10.9) and HSV-1 (>117), respect-
ively. Based on these results, both extracts were selected
to charact erize the antiviral activity.
Characterization of antiviral activity
In or der to characterize the antiviral activity against PV-
2 and HSV-1, different experimental approaches were
considered for the OE and AE of B. gaudichaudiana.
In the pretreatment assay, none of the extracts protected
Vero cells against PV-2 or HSV-1 infection after 7 h of in-
cubation at the evaluated concentrations (Figure 1).
When the virucid al activity was assessed, the OE did
not prove to have this effect against PV-2 since 10 and
20% of reduction of viral infectivity was obtained at r.t.
and 37°C, respectively. In contrast, higher values were
obtained for the AE against HSV-1 with values of 85%
and 97%, at r.t. and 37°C, respectively (Figure 1).
With the aim to determine whether the inhibitory ef-
fect of the extracts occurs during the adsorption or post-
adsorption steps of the viral cycle, different experimental
conditions were evaluated with 1xEC
of OE and AE
(Figure 2A). The results obtained demonstrated that B.
gaudichaudiana OE (30 μg/ml) reduced the formation
of PV-2 plaques when it was added after the adsorption
period. This reduction in the number of plaques was
similar to that obtained when the OE was present during
all the experimental time (Throughout) (Figure 2B).
In contrast, B. gaudichaudiana AE (35 μg/ml) inter-
fered in the adsorption step of HSV-1 to Vero cells and
caused an inhibition degree similar to that obtained
Table 2 Screening of antiviral activity of plant extracts
Plant name Extracts Yield
Baccharis gaudichaudiana OE 29 - - + +
AE 10 - + - -
Baccharis spicata OE 15.5 - - + +
AE 9 - + - -
Bidens subalternans OE 8.4 - - - -
AE 6.3 - - - -
Pluchea sagittalis OE 11 - +/ -+/
AE 11 - - - -
Tagetes minuta OE 7.5 - - +/ -
AE 7.8 - - - -
Tessaria absinthioides OE 13.5 - - + -
AE 15.3 - + - -
The antiviral activity was tested by the reduction of viral cytopathic effect
(CPE) assays.
(+) positive: reduction of viral CPE higher than 50% at both
concentrations tested.
(+/) positive/negative: reduction of viral CPE only achieved at 100 μg/ml.
() negative: without protection at 25 and at 100 μg/ml.
OE organic extract, AE, aqueous extract.
Yield (% w/w = g of extracts/100 g of dried and ground plant material).
Table 3 Antiviral activity of selected active extracts
Plant name Extract Virus CC
(μg/ml) EC
(μg/ml) EC
(μg/ml) SI
Baccharis gaudichaudiana OE PV-2 161.0 ± 2.5 30.1 ± 0.8 14.8 ± 1.5 10.9
VSV 114.0 ± 0.5 33.9 ± 3.8 4.8
AE HSV-1 > 2000 35.4 ± 1.2 17.1 ± 0.1 > 117
Baccharis spicata OE PV-2 114.3 ± 4.7 74 ± 4.7 19.3 ± 3.9 5.9
VSV 110.1 ± 1.6 23.8 ± 0.1 4.8
AE HSV-1 > 2000 61.3 ± 3.2 34.7 ± 3.2 > 57.6
Tessaria absinthioides OE PV-2 390.1 ± 3.2 61.1 ± 2.8 40.3 ± 5.6 9.7
AE HSV-1 > 2000 26.5 ± 1.5 19.1 ± 3.2 > 104
Acyclovir* HSV-1 > 9
1.9 ± 0.2
Guanidine* PV-2 > 84
0.2 ± 0.6
> 420
Ribavirin* VSV > 2
0.3 ± 1.2
> 6.7
cytotoxic concentration 50,
effective concentration 90,
effective concentration 50,
SI (Selectivity index) = CC
, OE organic extract, AE
aqueous extract. Results are shown as means ± SD, each time in triplicate.
*Acyclovir, Guanidine and Ribavirin were included as positive controls for the antiviral activity of HSV-1 and PV-2 and VSV, respectively. The CC
and EC
were expressed in mM (
), except for EC
of acyclovir that is expressed in μM(
Visintini Jaime et al. Virology Journal 2013, 10:245 Page 3 of 10
when it was present throughout the experimental time.
The reduction of 25% observed in the post-adsorption
condition could be due to the inhibitory effect of this ex-
tract on the adsorption steps on the subsequent HSV-1
replication cycles occurring during the 48 h incubation
period carried out at 37°C (Figure 2B).
Bioassay-guided fractionation of B. gaudichaudiana OE
B. gaudichaudiana OE was fractionated by a silicagel
column chromatography. Eight final fractions were
obtained according with their TLC profiles. The result s
obtained in the evaluation of the anti-PV-2 activity dem-
onstrated that F
was the most active fraction with a
SI = 56.4 and EC
= 2.1 ± 0.1 μg/ml followed by F
SI = 44.1 and EC
= 2.5 ± 0.3 μg/ml (Table 4). The
HPLC profile obtained for F
was similar to that of F
but based on the SI value and the yield, F
was selected
for further characterization (Add itional file 2).
To define the post-adsorption steps of the viral cycle
that could be targeted by F
, the effect of the addition of
=22μg/ml) at different times of infection
on PV-2 production at 10 h p.i. was evaluated (Figure 3).
The results obtained demonstrated that the maximum
inhibition level was exerted when F
was present before
4 h of infection.
A semipreparative HPLC of F
was then performed and
four subfractions (F
) were collected. The antiviral
activity against PV-2 was detected in F
μg/ml) and F
= 1.8 ± 0.1 μg/ml) (Figure 4). The
value of F
was higher than 100 μg/ml and the SI
was > 55.6. A major pure compound was isolated from
by semipreparative HPLC (Figure 5) and identified as
apigenin (Figure 6) by comparison of its spectral data
(Additional file 3 and Additional file 4) with literature
values [20] and by HPLC comparison with a reference
standard (Additional file 5). The antiviral activity of apige-
nin was determined by plaque assay with EC
3.3 μM. Its CC
value was 230.7 ± 4.4 μM; in conse-
quence the SI was 18.9. The apigenin standard exhibited
similar values of EC
and CC
(data not shown).
Several Baccharis species have been reported to have anti-
viral activity: B. genistelloides [21], B. teindalensis [22], B.
trinervis [23], B. coridifolia [24] and B. articulata [25] but
this is the first report on the antiviral activity of B.
gaudichaudiana and B. spicata. Although the virucidal
activity of T. absinthioides essential oil was reported previ-
ously against HSV-1 and Junín virus [13], this is the first
report of the antiviral activity of the OE and AE obtained
from this plant.
In the characterization of the antiviral activity of B.
gaudichaudiana AE , this extract did not a ffe ct HSV-1
replication when it wa s adde d t o t he cell culture before
infection, thus , it is unlikely that its antiviral activity
could be due to direct effe ct s on the host s cell. On the
Figure 2 Effect of B. gaudichaudiana OE and AE in the adsorption and post-adsorption steps of PV-2. A. Scheme of addition of OE or AE.
Open and black arrows indicate the absence and presence of extract, respectively. B.- Percentage of viral inhibition under different experimental
conditions. 1xEC
was used for the experiments. Data represented % of virus inhibition compared to untreated control as mean ± SD (n = 3),
each time by quadruplicate.
Figure 1 Virucidal activity and the effect of pretreatment with
B. gaudichaudiana OE and AE. The virucidal activity and the
pretreatment of 10xEC
(OE= 300 μg/ml AE = 350 μg/ml) and
(OE= 30 μg/ml, AE = 35 μg/ml) were evaluated against PV-2
and HSV-1, respectively. Data represent % of virus inhibition
compared to untreated controls as mean ± SD (n = 3), each time
in quadruplicate.
Visintini Jaime et al. Virology Journal 2013, 10:245 Page 4 of 10
other hand, the results of the virucidal assays suggest
that this extract could interact with viral particles a nd
inactivate them. Data also indicated that HSV-1 infe c-
tion was significant impaired only if the AE wa s
present at the time of adsorption. Therefore, these
result s su ggest that AE may exe rt its antiviral activity
by inactivation of viral particles at high concentra-
tions and possibly by interference of the adsorp-
tion step of the virus to the cells at non-virucidal
Upon characterizing the antiviral activity of B. gaudi
chaudiana OE against PV-2, it could be considered that
this extract had a true antiviral activity against this virus
because of its ability to inhibit the viral cycle, parti-
cularly during the post-adsorption period. In the present
study, B. gaudichaudiana OE was selected for fur ther
purification and isolation of antiviral principles by
bioassay-guided fractionation. The most active fraction
obtained, F
, exerted the maximum inhibition of PV-2
replication when it was present before 4 h p.i. At this
time of the poliovirus replication cycle, the synthesis of
viral RNA is maximum [26,27]. Taking into account the
results obtained, it can be deduced that F
might exert
its antiviral activity at an intermediate stage of virus life
cycle and could interfere with viral RNA synthesis and
polyprotein processing/synthesis.
From this active fraction the flavonoid apigenin (5, 7-
dihydroxy-2-(4-hydroxylphenyl)-4H chromen-4-one) was
isolated. This compound has previously been reported
from B. gaudichaudiana [28]. It has been demonstrated
that apigenin is active against different viruses, including
avian influenza H5N1 virus strain, hepatitis C virus, HSV
and human immunodeficiency virus [29-32].
Although apigenin exhibited antiviral activity against
PV-2 (EC
= 12.2 ± 3.3 μM), HPLC profile of F
showed the presence of other minor compounds which
could be responsible, altogether with apigenin, of the
antiviral activity observed.
Further studies are under way to characterize the
mechanism of action of apigenin against PV-2.
To our knowledge, this is the first time that the anti-
viral activity of B. gaudichaudiana is reported and the
anti-poliovirus activity of apigenin is determined.
In this study we have shown that the organic extract of
B. gaudichaudiana shows high antiviral effect against
PV-2 and the isolated compound, apigenin could be, at
least in part, responsible for the antiviral activity
Table 4 Antiviral activity of fractions of B. gaudichaudiana
Fraction Yield (%) CC
(μg/ml) EC
(μg/ml) SI
1.43 396.7 ± 14.4 15.4 ± 1.0 25.8
1.35 196.1 ± 6.1 7.6 ± 0.4 25.8
2.56 118.5 ± 6.5 2.1 ± 0.1 56.4
0.66 110.2 ± 7.9 2.5 ± 0.3 44.1
2.14 390.9 ± 10.9 38.4 ± 3.8 10.2
1.68 390.4 ± 10.4 33.1 ± 4.8 11.8
0.75 412.3 ± 7.1 27.4 ± 3.9 15.0
0.31 729 ± 3.1 20.8 ± 3.6 35.1
cytotoxic concentration 50,
effective concentration 50,
(Selectivity index) = CC
Yield (% w/w = g of fraction/100 g of OE).
Results are shown as mean ± SD (n=3), each time in quadruplicate.
Figure 3 Effect of F
on PV-2 replication cycle. A. Kinetics of PV-2 extracellular production during one replication cycle Vero cell monolayers
were infected with PV-2 ( m.o.i. = 10). Viral titers were determined at different hours by plaque assay. B. Effect of addition of F
on the PV-2
production during a one step replication cycle At different h p.i. after the adsorption period, F
(22 μg/ml) was added and the extracellular viral
production was determined at 10 h p.i. of incubation at 37°C, by the plaque assay. Data represent % of virus production respect to untreated
control. The viral production at 10 h p.i. in the kinetic curve of control virus was considered 100%. * p < 0.05 vs 0 and vs 2 h (one-way ANOVA
with Bonferroni a posteriori test).
Visintini Jaime et al. Virology Journal 2013, 10:245 Page 5 of 10
observed. Further studies are necessary for a better un-
derstanding of the mechanism of action of apigenin.
Moreover, since the aqueous extract of B. gaudichau
diana wasactiveagainstHSV-1,thebioassayguidedfrac-
tionation of this extract will be carried out.
Plant material
Plant samples (aerial parts with flowers) were collected
between 2008 and 2010 in their places of origin in
Argentina. Voucher specimens are deposited as follows:
B. gaudichaudiana (1655): Botany Herbarium at Facultad
de Ciencias Bioquímicas y Farmacéuticas, Universidad
Nacional de Rosario, Argentina; B. spicata (BAF 711),
Bidens subalternans (BAF 704), Pluchea sagittalis (BAF
709) and Tagetes min uta (BAF 714): Herbarium at Museo
de Farmacobotánica, Facultad de Farmacia y Bioquímica,
Universidad de Buenos Aires; Tessaria absinthioides
(Slanis-Juarez 1041): Herbarium of Fundación Miguel A.
Lillo, Universidad de Tucumán. Botanical and vernacular
names, popular uses and reported chemical composition
are shown in Table 1.
Extraction of plant material
Dried aerial parts of each plant (10 g) were reduced to pow-
der and extracted by soaking in 100 ml of dichloromethane:
methanol (1:1) at room temperature (r.t.) for 24 h and then
vacuum-filtered. The process was repeated twice and the
filtrates were combined and dried under vacuum to obtain
the organic extract (OE). The marc of the plant material
was further extracted with distilled water under the same
conditions. T he aqueous extracts (AE) were lyophilized. For
the antiviral assays, OE and AE were dissolved in dimethyl-
sulfoxide and sterile distilled water, respectively.
Cells and virus strains
Vero cells (ATCC CCL 81) were obtained from Asociación
Banco Argentino de lulas and cultured in growth
medium consisting of Eagles Minimal Essential Medium
(E-MEM) supplemented with 10% fetal bovine serum
(FBS) (PAA), 100 μg/ml streptomycin, 100 IU/ml penicil-
lin, 2 mM L-glutamine, 2.25 g/L sodium bicarbonate and
non-essential amino acids (100 μM) (Gibco), at 37°C in a
5% CO
incubator. The infection medium (IM), used for
the antiviral assays, was the same as the growth medium
but 2% FBS was added instead. The plaque medium (PM)
was IM supplemented with 1% methylcellulose (Sigma).
Madin-Darby Bovine Kidney cells (MDBK) (ATCC CLL
22) were grown in growth medium supplemented with
Figure 4 Antipoliovirus (PV-2) activity of subfractions derived
from F
. The antiviral activity of each subfraction was determined
by the reduction of plaque assay. Results are shown as mean ± SD
(n = 3), each concentration in quadruplicate.
Figure 5 HPLC profile of F
. HPLC: RP-18 column, using a water (A)-methanol (B) gradient: 02 50% A; 215 min: 50 98% A, 1525 min:
isocratic 98% A, 2630 min: 98 50% A, flow rate=1 ml/min, monitored at 336 nm. The insert shows the UV adsorption spectra of the major
peak detected.
Visintini Jaime et al. Virology Journal 2013, 10:245 Page 6 of 10
10% of γ-irradiated FBS. IM for the MDBK cell line was
supplemented with 2.5% horse serum (Gibco).
The herpes simplex type 1 (HSV-1) F strain, the polio-
virus type 2 (PV-2) Sabin strain and the bovine viral
diarrhea virus (BVDV:NADL strain cytopathic biotype
were kindly provided by Dr. Albert Epstein, Dr. María
Cecilia Freire (ANLIS-Instituto Dr. Carlos G. Malbrán,
Argentina) and Dr. Laura Weber (INTA, Ca stelar,
Argentina), respectively. VSV, Indiana strain (ATCC VR-
1421), was purchased from ATCC. Virus stocks of HSV-
1, PV-2 and VSV were propagated and quantified in
Vero cells. BVDV was propagated and quantified in
MDBK cells. Virus quantification was performed by
plaque assay method as number of plaque forming units
per ml (p.f.u./ml). All virus stocks were stored at 70°C
until used.
Screening of antiviral activity
The antiviral activity of each plant extract was screened in
96-well culture plates by measuring the reduction of the
viral cytopathic effect (CPE). Confluent Vero and subcon-
fluent MDBK cell monolayers were infected with HSV-1,
PV-2 or VSV or with BVDV, respectively, at a multiplicity
of infection (m.o.i.) of 0.01 p.f.u./cell in the presence of 25
and 100 μg/ml of each OE/AE. Infected cells in the ab-
sence of extract as control virus and mock-infected cells
with and without extract as control cells and cytotoxicity
control were included. Plates were incubated at 37°C in a
humidified atmosphere containing 5% CO
until 90% of
viral CPE in the CV was reached. The reduction of viral
CPE was determined by measuring cell viability by the
tetrazolium salt/phenazine methosulfate (MTS/PMS) col-
orimetric assay (CellTiter 96 Promega, Madison, WI,
USA). The absorbance at 490 nm was measured in a
Multi-Mode microplate reader (Synergy HT, BioTek). Re-
sults of the screening were expressed as positive (+) (re-
duction in the CPE at both concentrations tested),
negative () (absence of reduction in the CPE) and (+/)
(reduction in CPE only at 100 μg/ml).
Cytotoxicity assay: determination of cytotoxic
concentration 50 (CC
The cytotoxic eff ect of B. gaudichaudiana, B. spicat a
and T. absinthioides OE and AE on Vero cells wa s de-
termined by the MTS/PMS method, a s pre viously de-
scribed [ 33]. Briefly, sub confluent monolayers of Vero
cells (8×10
cells/well; 24 h culture) were incubated in
quadruplicate in 96-multiwe ll plates in the presence of
two-fold dilutions of the extracts for 72 h at 37°C. Cell
viability (%) was calculated for each concentration a s
and Abs
are the absorbance readings for t he wells with and
without extract, respectively. The CC
is defined as
the concentration that reduced cell viability by 50%
with respect to controls without drug. The CC
was derived from the corresponding doseresponse
cur ves. The maximum non-cytotoxic concentration
(MNCC) is defined as the maximum concentration of
the extract that leaves 100% of viable cells.
Antiviral assay: determination of effective concentration
50 (EC
The effective concentration 50 (EC
of extract that reduces the number of viral plaques by 50%
with respect to control virus (without extract). This par-
ameter was determined by the plaque reduction assay.
Briefly, monolayers of Vero cells grown in a 24-well plate
(24 h; 5% CO
; 37°C) were infected with 100 p.f.u./well of
PV-2, VSV or HSV-1 in either the absence or presence of
serial two-fold dilutions from the MNCC of B. gaudi-
chaudiana , B. spicata and T. absinthioides extracts
(treated). After 45 min incubation at 37°C, the viral inocu-
lum was removed, and the cell monolayers were washed
with phosphate buffer saline (PBS) and overlaid with PM
supplemented with the corresponding concentrations of
each extract. PM without extract was added in CC and
CV wells. After 24 h at 37°C for PV-2 and VSV or 48 h for
HSV-1, cell monolayers were fixed and stained with 0.75%
crystal violet in methanol:water (40:60) and viral plaques
were counted. Reduction of plaques (%) was calculated as:
[1-( plaques
)] × 100. The EC
values were calculated by regression analysis of the dose
response curves generated with the data.
The selectivity index (SI) was calculated as the CC
Acyclovir (Filaxis); Guanidine.HCl (Sigma-Aldrich, St.
Louis, MO) and Ribavirin (MP Biomedicals, LLC) were
tested simultaneously a s positive controls for HSV-1,
PV-2 and VSV, respectively.
Chromatographic profile- thin layer chromatography
Chromatographic analysis of positive OE were performed
by thin layer chromatography (TLC) on silica gel layers
Figure 6 Chemical structure of apigenin: 5, 7-dihydroxy-2-
(4-hydroxylphenyl)-4H chromen-4-one, C
, MW: 270.24.
Visintini Jaime et al. Virology Journal 2013, 10:245 Page 7 of 10
(Silica gel 60 F
EMD Chemicals Inc.) using a- ethyl acet-
ate:toluene:formic acid:methanol (2:2:1:1) and Natural
Product Reagent (NPR - 2-aminoethildiphenilboric acid -
Sigma) as visualization reagents; and b- toluene:ethylacetate
(5:5) and sulphuric/anisaldehyde (SAni) as reagent. The
positive AE were tested on: a) silica gel layers using
ethylacetate:methanol:water (50:6:5) and SAni reagent; and
b) Cellulose plate (Polygram® CEL 300 UV
Nagel) using acetic acid 15% and NPR as reagent. In all
cases, the TLC plates were visualized under UV light (254
and 366 nm) and visible light.
Characterization of the antiviral activity
Virucidal activity
The virucidal activity was measured by in vitro incuba-
tion of viruses with the extract s. Briefly, 10
p.f.u. of PV-
2 or HSV-1 were incubated for 30 min at r.t. or at 37°C
with 10xEC
of B. gaudichaudiana OE (300 μg/ml ) or
AE (350 μg/ml), respectively. Simu ltaneously, the same
amount of virus was incubated with IM without extract
as control. The residual infectious viruses were quanti-
fied by viral plaque assays.
Pretreatment assays
To assess the effect of the pretreatment with B.
gaudichaudiana extracts, Vero cell monolayers seeded
in 24-well plates were treated for 7 h at 37°C with two
concentrations of the extract 10xEC
and 1xEC
300 and 30 μg/ml and AE: 350 and 35 μg/ml, respect-
ively). Then, the medium was removed and washed with
PBS, and the cell monolayers were infected with 100 p.f.
u. of PV-2 or HSV-1/well in the absence of the extracts.
Mock-infected cells (CC ) and cells pretreated with IM
(CV) were included in each assay. After 45 min at 37°C,
the viral inoculum was removed and PM without extract
was added and further incubated at 37°C for 24 or 48 h.
Finally, the number of viral plaques was determined.
Time-of-addition assay
To study the effect of the extracts in the adsorption and
post-adsorption events, three different treatments with
B. gaudichaudiana OE (1xEC
=30μ g/ml) against PV-
2 or AE (1xEC
=35μg/ml) against HSV-1 were carried
out. B. gaud ichaudiana OE and AE were present: (i)
only during the adsorption period (Adsorption); (ii) after
adsorption and until the end of the experiment (Post-
Adsorption), and (iii) during and after the adsorption
(Throughout). Briefly, Vero cell monolayers cultured in
24-well plates were precooled for 1 h at 4°C. Cells were
then infected with 100 p.f.u. of virus/well in the presence
or absence of OE/AE and further incubated at 4°C for 1
h allowing only the adsorption step of the viral particles
to the cells (Adsorption). Cell monolayers were washed
with PBS, and then PM with or without extract was
added. The number of viral plaques was determined
after 24 h and 48 h for PV-2 and HSV-1, respectively.
Bioassay-guided fractionation of Baccharis
gaudichaudiana OE
B. gaudichaudiana aerial parts (500 g) were air-dried,
ground to powder and extracted with dichloromethane:
methanol (1:1) and the extract was taken to dryness. Thirty
grams of this OE was fractionated by silica gel 60 (500 g)
column chromatography eluted with a step gradient of
hexane:ethylacetate (100:0 to 0:100) and ethylacetate:
methanol (100:0 to 0:100) to afford 21 fractions of 500 ml
each. Eluates were monitored by thin-layer chromatog-
raphy (TLC) on silica gel 60 F
using toluene-ethyl acet-
ate (1:1) and cellulose layers using acetic acid 40% and
combined into eight final fractions (F
to F
) according to
their TLC profiles.
Fraction F
was further fractionated by a semipreparative
reverse-phase HPLC (Waters 2996 Photodiode Array De-
100, 5 μm, LiChroCART 125×4 Merck). The injection vol-
ume was 50 μl. Elution was performed at a flow rate of 1 ml/
methanol (B): 015 min: isocratic 50% A, 1525 min: 50
98% A, 2530 min: isocratic 98% A, 3031 min: 98 50%
A. Eluates were monitored at 254 nm. Eluates were collected
into four subfractions: F
(013 min), F
(1320 min), F
(2025 min) and F
(2530 min).
The F
subfraction was subjected to reverse-phase
HPLC on RP-18 column (LiChrospher® 100, 5 μm,
LiChroCAR T 125×4 Merck), using a water (A)-methanol
(B) gradient: 02 50% A; 215 min: 50 98% A, 1525
min: isocratic 98% A, 2630 min: 98 50% A and a flow
rate=1 ml/min and a pure compound was isolated. Eluates
were monitored at 336 nm.
The anti-PV-2 activity of fractions F
and sub-
fractions F
and the pure compound was determined
by viral plaque reduction assay at concentrations ranging
from 100 to 0.1 μg/ml in Vero cells. The cytotoxicity and
SI were also evaluated as previously described.
Identification of apigenin
The pure compound obtained from F
was identified by
ultraviolet spectroscopy (UV) (Jasco V-630), infrared spec-
troscopy (IR) (Nicolet 380 FT-IR-Smart Multi Bruce
HATR, Zn Se 45°) and HPLC/DAD by comparison with
authentic sample (Sigma-Aldrich, St. Louis, MO) and
comparison with literature data.
One-step replication curve: effect of fraction F
on PV-2
Confluent Vero cell monolayersculturedina96-wellplate
were infected with PV-2 (m.o.i. = 10) for 1 h at 4°C. Follow-
ing the adsorption period, cells were washed three times, and
Visintini Jaime et al. Virology Journal 2013, 10:245 Page 8 of 10
(22 μg/ml=10xEC
infection (p.i): 0, 2, 4, 6 and 8 h. Cells were further incubated
up to 10 h. At this time, supernatan ts were collected and
clarified by centrifugation (3,500 × g at 4°C) and the virus
production was deter mined by viral plaque assays.
Statistical analysis
Data are presented as means ± standard deviation (SD). A
one-way ANOVA with Bonferroni a posteriori test was
used to compare differences between groups. A p < 0.05
was considered significant. The EC
and CC
were calculated using GraphPad Prism software v. 5.01.
Additional files
Additional file 1: TLC profile of OE and AE of B. gaudichaudiana,
B. spicata and T. absinthioides. Right Panels (A and B) showed the OE
profiles in silica gel in (A-) ethylacetate:toluene:formic acid:methanol
(2:2:1:1) revealed with NPR at 366 nm; and (B-) toluene:ethylacetate (5:5)
revealed with AniS, at visible light. Left panels (C and D) correspond to
AEs: (C-.) silica gel and ethylacetate:methan ol:water (100:10:13) and SAni,
at visible light; and (D-) AE profile in cellulose with AcH 15% and NPR at
366 nm. BG (B. gaudichaudiana); BS (B. spicata) and TA (T. absibthioides).
Additional file 2: HPLC profile of F
and F
from the OE of
B. gaudichaudiana. A gradient of mobile phase system consisting of
water (A) and MeOH (B) used was: 015 min: 2 98% A; 1520 min:
isocratic 98% A; 2021 min: 98 2% A.
Additional file 3: UV spectra of purified apigenin. A.- UV spectra with
methanol (MeOH) and MeOH with sodium methoxide (MeONa); B.- UV
spectra with MeOH, MeOH with aluminium chloride (AlCl3), MeOH+AlCl3+
chloridric acid (HCl) and MeOH+AlCl3+HCl 5 minutes later; C.- UV spectra
with MeOH, MeOH+ sodium acetate (AcONa) and MeOH+AcONa+ boric
acid (H3BO4).
Additional file 4: IR spectra of purified apigenin.
Additional file 5: HPLC of standard apigenin (Sigma). The inserts
show the UV adsorption spectra of the major peak detected. HPLC with a
RP-18 column, using a water (A)-methanol (B) gradient: 02 50% A; 215
min: 50 98% A, 1525 min: isocratic 98% A, 2630 min: 98 50% A,
flow rate=1 ml/min monitored at 336 nm.
Competing interests
The authors declare that they have no competing interests.
Authors contributions
MFVJ designed and carried out the antiviral and cytotoxicity studies, the
extract preparation, TLC profiles and drafted the manuscript. FR carried out
the fractionation of Bg OE and the HPLC analyses. LM and RHC participated
in the design of the study. VM and LVC conceived the whole study and
edited the manuscript. All authors read and approved the final manuscript.
This work was supported by grants B045; B037 from the Universidad de
Buenos Aires (UBACyT 20082011); and grant PIP 112-200801-01169 from the
Consejo Nacional de Investigaciones Científicas y Tecnológicas, Argentina.
We acknowledge Martha Gattuso and Susana Gattuso from Universidad
Nacional de Rosario, Gustavo Giberti from Universidad de Buenos Aires and
Alberto Slanis from Instituto Miguel Lillo from Universidad Nacional de
Tucumán for collection and identification of plant material. We also thank
Pharm. Daiana Retta for providing B. gaudichaudiana plant material;
Dr. Eliana F. Castro for encouraging discussions Ms. María Teresa Argerich
(CONICET) for her technical assistance.
Author details
Cátedra de Virología, Facultad de Farmacia y Bioquímica, Universidad de
Buenos Aires, Junín 956, 4ºP, Ciudad de Buenos Aires, 1113, Argentina.
Cátedra de Farmacognosia, Instituto de Química y Metabolismo del
Fármaco (IQUIMEFA), Facultad de Farmacia y Bioquímica, Universidad de
Buenos Aires, Junín 956, 2ºP, Ciudad de Buenos Aires, Argentina.
Received: 20 November 2012 Accepted: 24 July 2013
Published: 27 July 2013
1. De Clercq E, Field HJ: Antiviral prodrugs the development of successful
prodrug strategies for antiviral chemotherapy. Br J Pharmacol 2006,
2. Kitazato K, Wang Y, Nobayashi K: Viral infectious disease and natural
products with antiviral activity. Drug Discov Ther 2007, 1:1422.
3. Giberti G: Ethnobotanical data and herbarium information from
Argentina: Tools for medicinal plant research. In South American Medicinal
Plants as a Potential Source of Bioactive Compounds. 1st edition. Edited by
Martino V, Muschietti LV. Kerala: Transworld Research Network; 2008:113.
4. Barboza GE, Cantero JJ, Núñez C, Pacciaroni A, Ariza Espinar LA: Medicinal
plants: a general review and a phytochemical and
ethnopharmacological screening of the native argentine flora.
KURTZIANA 2009, 34:7365.
5. Akaike S, Sumino M, Sekine T, Seo S, Kimura N, Ikegami F: A new ent-
clerodane diterpene from the aerial parts of Baccharis gaudichaudiana.
Chem Pharm Bull 2003, 51:197199.
6. Zardini EM: Etnobotánica de Compuestas Argentinas con especial
referencia a su uso farmacológico. Acta Farm Bon 1984, 3:7799. and
7. Martinez Crovetto R: Las plantas utilizadas en medicina popular en el
Noroeste de Corrientes. República Argentina. Miscelánea Fundación Miguel
Lillo 1981, 69:7139.
8. Martinez Crovetto R: Estudios Etnobotánicos. I. Nombres de plantas y su
utilidad según los indios Tobas del este de Chaco. Bonplandia 1964,
9. de Souza GC, Haas AP, von Poser GL, Schapoval EE, Elisabetsky E:
Ethnopharmacological studies of antimicrobial remedies in the south of
Brazil. J Ethnopharmacol 2004, 90:135143.
10. Toursarkissian M: Plantas medicinales de la Argentina: sus nombres botánicos,
vulgares, usos y distribución geográfica. Buenos Aires: Eds: Hemisferio Sur;
11. Scrivanti LR, Zunino MP, Zygadlo JA: Tagetes minuta and Schinus areira
essential oils as allelopathic agents. Biochem Syst Ecol 2003, 31:563572.
12. Tereschuk ML, Riera MVQ, Castro GR, Abdala LR: Antimicrobial activity of
flavonoids from leaves of Tagetes minuta. J Ethnopharmacol 1997,
13. García CC, Talarico L, Almeida N, Colombres S, Duschatzky C, Damonte EB:
Virucidal activity of essential oils from aromatic plants of San Luis,
Argentina. Phytother Res 2003, 17:10731075.
14. Antoine TE, Park PJ, Shukla D: Glyc oprot ein targ et ed t herapeuthi cs: a
new era of anti-herpes si mplex virus-1 therapeutic. Rev Med Virol.
in press.
15. Piret J, Boivin G: Resistance of herpes simplex viruses to nucleoside
analogues: mechanisms, prevalence, and management. Antimicrob Agents
Chemother 2011, 55:459472.
16. World Health Organization: Poliomyelitis, Fact sheet no. 114. http://www.who.
17. Couzin J: Report concludes polio drugs are neededafter disease is
eradicated. Science 2006, 311:1539.
18. Buckwold VE, Beer BE, Donis RO: Bovine viral diarrhea virus as a surrogate
model of hepatitis C virus for the evaluation of antiviral agents. Antiviral
Res 2003, 60:115.
19. Whelan SPJ: Vesicular Stomatitis Virus. In Encyclopedia of Virology. 3rd
edition. Edited by Mahy BWJ, van Regenmortel MHV. Academic Press,
Elsevier Ltd; 2008:291299.
20. Mabry TJ, Markham KR, Thomas MB: The Systematic Identification of
Flavonoids. Berlin: Springer Verlag; 1970:81.
21. Abad MJ, Bermejo P, Gonzales E, Iglesias I, Irurzun A, Carrasco L: Antiviral
activity of Bolivian plant extracts. Gen Pharmacol 1999, 32:499503.
Visintini Jaime et al. Virology Journal 2013, 10:245 Page 9 of 10
22. Abad MJ, Bermejo P, Sanchez Palomino S, Chiriboga X, Carrasco L: Antiviral
activity of some South American medicinal plants. Phytother Res 1999,
23. Sanchez Palomino S, Abad MJ, Bedoya LM, García J, Gonzales E, Chiriboga X,
Bermejo P, Alcami J: Screening of South American plants against human
immunodeficiency virus: preliminary fractionation of aqueous extract
from Baccharis trinervis. Biol Pharm Bull 2002, 25:11471150.
24. García CC, Rosso ML, Bertoni MD, Maier MS, Damonte EB: Evaluation of the
antiviral activity against Junin virus of macrocyclic trichothecenes
produced by the ypocrealean epibiont of Baccharis coridifolia. Planta Med
2002, 68:209212.
25. Torres CV, Domínguez MJ, Carbonari JL, Sabini MC, Sabini LI, Zanon SM:
Study of antiviral and vir ucidal activities of aqueous extract of
Baccharis articulata against Herpes suis virus. Nat Prod Commun 2011,
26. Genovese D, Catone S, Farah ME, Gambacorta A, Fiore L: Isolation and
biological characterization of 3(2H)-isoflavene-resistant and -dependent
poliovirus type 2 Sabin mutants. J Gen Virol 1999, 80:157167.
27. Verheyden B, Lauwers S, Rombaut B: Quantitative RT-PCR ELISA to
determine the amount and ratio of positive- and negative strand viral
RNA synthesis and the effect of guanidine in poliovirus infected cells.
J Pharm Biomed Anal 2003, 33:303308.
28. Fullas F, Hussain RA, Chai HB, Pezzuto JM, Soejarto DD, Kinghorn AD:
Cytotoxic constituents of Baccharis gaudichaudiana. J Nat Prod 1994,
29. Sithisarna P, Michaelisa M, Schubert-Zsilaveczb M, Cinatl J Jr: Differential
antiviral and anti-inflammatory mechanisms of the flavonoids biochanin
a and baicalein in h5n1 influenza a virus-infected cells. Antiviral Res 2013,
30. Manvar D, Mishra M, Kumar S, Pandey VN: Identification and evaluation of
anti hepatitis C virus phytochemicals from Eclipta alba. J Ethnopharmacol
2012, 144:545554.
31. Chiang LC, Ng LT, Cheng PW, Chiang W, Lin CC: Antiviral activities of
extracts and selected pure constituents of Ocimum basilicum. Clin Exp
Pharmacol Physiol 2005, 32:
32. Critchfield JW, Butera ST, Folks TM: Inhibition of HIV activation in latently
infected cells by flavonoid compounds. AIDS Res Hum Retroviruses 1996,
33. Finkielsztein LM, Castro EF, Fabián LE, Moltrasio GY, Campos RH, Cavallaro
LV, Moglioni AG: New 1-indanone thiosemicarbazone derivatives active
against BVDV. Eur J Med Chem 2008, 43:17671773.
Cite this article as: Visintini Jaime et al.: In vitro antiviral activity of plant
extracts from Asteraceae medicinal plants. Virology Journal 2013 10:245.
Submit your next manuscript to BioMed Central
and take full advantage of:
Convenient online submission
Thorough peer review
No space constraints or color figure charges
Immediate publication on acceptance
Inclusion in PubMed, CAS, Scopus and Google Scholar
Research which is freely available for redistribution
Submit your manuscript at
Visintini Jaime et al. Virology Journal 2013, 10:245 Page 10 of 10
... Results are shown in Table 5. Several studies have confirmed the antiviral potential of plants (Denaro et al., 2020, Jaime et al., 2013. The antiviral activity of the extracts can also be attributed with the presence of phenolic acids in extracts with documented antiviral activity such as luteolin quantified in Sk-EA which in recent studies has shown that it inhibits the secretion of Hepatitis B e-antigen (HBeAg) in HepG2.2.15 cells that bear the HBV genome and Hepatitis B surface antigen (HBsAg) suggests that luteolin acts as a potential anti-HBV agent (Bai et al., 2016), apigenin quantified in Sk-EA and Sk-Aq, inhibits the replication of EV71 which causes hand, foot and mouth disease (HFMD) by disturbing association of viral RNA with trans-acting factors and regulating cellular JNK pathway (Dai et al., 2019) and quercetin quantified in Sk-Aq, is effective against various viral infections by either blocking the virus entry or inhibiting viral replication enzymes such as viral polymerases (Agrawal et al., 2020). ...
... Pharmacokinetic characteristics, such as absorption, distribution, metabolism, and excretion, can potentially be altered to improve a substance's potential to be used as a therapeutic agent. It is critical that the World Health Organization (WHO), FDA, European Medicines Agency (EMA), World Trade Organisation (WTO), International Conference on Harmonization (ICH), World Intellectual Property Organization (WIPO) collaborate on the development of specific protocols for the discovery of novel bioactive compounds [101,102]. Indeed, there is an urgent need for specific protocols for the discovery of novel bioactive compounds, and related organizations, companies, and agencies must collaborate on this effort. A wide range of serious illnesses brought on by lethal viruses have already showed promise in the treatment of plant-derived medicines, which should be tested against SARS-CoV-2. ...
Full-text available
According to recent reports out of India, a new strain of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) B1.1.529 Omicron virus has emerged. In comparison to the Wuhan (WHU) strain and the delta variant, this variant showed a far stronger effect on the angiotensin converting enzyme2 (ACE2) receptor. There are several medicinal compounds in plant metabolites, and their diverse chemical structures make them ideal for the treatment of serious illnesses. It's possible that some of these could be useful alternative pharmaceuticals, as well as a starting point for the repurposing of existing medications and new chemical discoveries. SARS-CoV-2 infection triggered a worldwide epidemic of the severe acute respiratory syndrome (SARS). There have been trials for different therapies for SARS-CoV-2 and so also there are recent announcements of extensive research into the development of viable medicines for this global health calamity. After a thorough examination of plant-derived treatments for COVID-19, investigators in the current study decided to focus on plant-derived secondary metabolites (PSMs). According to some researchers, new MDR (Multi-Drug Resistant) antibiotics may one day be developed due to the adaptability of secondary metabolites. Identifying plant metabolites that can treat a wide range of viral infections was one of the study's aims. Many natural medications that could be recommended for the treatment of COVID-19 were discovered as a result of this research, including remedies from plant families, viral candidates that are susceptible, antiviral assays, and mechanisms of therapeutic action. The findings of this study will inspire further research and speed up the development of new antiviral plant-based medications.
... They can prevent viruses from attaching to cells and infecting other cells by interacting with different viral replication stages and also inhibit the process of protein synthesis. Flavonoids have been discovered to inhibit viruses in a variety of ways [40]. ...
Full-text available
Plant bioactive compounds, particularly apigenin, have therapeutic potential and functional activities that aid in the prevention of infectious diseases in many mammalian bodies and promote tumor growth inhibition. Apigenin is a flavonoid with low toxicities and numerous bioac-tive properties due to which it has been considered as a traditional medicine for decades. Apigenin shows synergistic effects in combined treatment with sorafenib in the HepG2 human cell line (HCC) in less time and statistically reduces the viability of tumor cells, migration, gene expression and apoptosis. The combination of anti-cancerous drugs with apigenin has shown health promoting potential against various cancers. It can prevent cell mobility, maintain the cell cycle and stimulate the immune system. Apigenin also suppresses mTOR activity and raises the UVB-induced phago-cytosis and reduces the cancerous cell proliferation and growth. It also has a high safety threshold, and active (anti-cancer) doses can be gained by consuming a vegetable and apigenin rich diet. Apig-enin also boosted autophagosome formation, decreased cell proliferation and activated autophagy by preventing the activity of the PI3K pathway, specifically in HepG2 cells. This paper provides an updated overview of apigenin's beneficial anti-inflammatory, antibacterial, antiviral, and anti-cancer effects, making it a step in the right direction for therapeutics. This study also critically analyzed the effect of apigenin on cancer cell signaling pathways including the PI3K/AKT/MTOR, JAK/STAT, NF-κB and ERK/MAPK pathways. Citation: Abid, R.; Ghazanfar, S.; Farid, A.; Sulaman, S.M.; Idrees, M.; Amen, R.A.; Muzammal, M.; Shahzad, M.K.; Mohamed, M.O.; Khaled, A.A.; et al. Pharmacological Properties of 4′, 5, 7-Trihydroxyflavone (Apigenin) and Its Impact on Cell Signaling Pathways. Molecules 2022, 27, 4304.
... It is popularly known as chitoco and lucera, it is widely used in folk medicine as a purgative, digestive, antispasmodic, to treat skin diseases (Campos-Navarro & Scarpa, 2013;Bieski et al., 2015), amenorrhea, inflammation (De Albuquerque et al., 2007), liver disease, stomach pain, cough suppressant, antipyretic and antiseptic (Filipov, 1994). Studies with P. sagittalis have shown that the species has several biological properties such as wound healing (Alerico et al., 2015), antinociceptive (Figueredo et al., 2011) antifibrotic (Ouriques et al., 2018), antioxidant (Pérez-García et al., 2001;Parejo et al., 2003), activity on the respiratory burst and the stress protein synthesis (Pérez-García et al., 2001), antiviral (Simões et al., 1999;Visintini Jaime et al., 2013), citotoxic (Monks et al., 2002), anti-inflammatory (Pérez et al., 1995;Gorzalczany et al., 1996;Pérez-García et al., 1996;Pérez-García et al., 2005;Schmidt et al., 2009) and ability to change the absorptive characteristics of the gastrointestinal tract (Burger et al., 2000). The presence of compounds that inhibit photosynthesis (Carvalho et al., 2019) and with insecticidal activity (Vera et al., 2008;Sosa et al., 2017) has also been reported. ...
Full-text available
Pluchea sagittalis (Asteraceae) is widely distributed in South America and used as a medicinal plant to treat various diseases. The objectives of the work were to evaluate the antioxidant and antifungal activities of the ethanol extract and fractions from the aerial parts of P. sagittalis, as well as to identify the chemical constituents of the most active sample by liquid chromatography coupled to mass spectrometry with electrospray ionization (LC-MS-ESI). The ethanolic extract obtained by maceration of aerial parts showed relevant activity in DPPH free radical scavenging (IC50 = 33.9 µg mL-1) and presented an anti-Candida effect with MIC values of 93.75 µg mL-1 for C. albicans and 187 µg mL-1 for C. glabrata and C. tropicalis. However, the results found for the chloroform fraction prepared from the extract were more significant. This fraction showed the highest antioxidant activity with an IC50 of 12.5 µg mL-1 and inhibited the growth of Candida spp. with MIC values ranging from 46.87 to 93.75 µg mL-1. The qualitative phytochemical screening of this fraction indicated the presence of phenolic compounds and flavonoids. Twenty-three metabolites were identified by LC-MS in the chloroform fraction including caffeoylquinic acids derivatives, flavones and fatty acids, which have recognized antioxidant and antimicrobial effects. The results of the activities, as well as the chemical constituents present in the chloroform fraction, reveal the potential of this fraction as a source of antioxidant and antifungal agents.
... The natural products to be studied were selected mainly based on availability. In the case of plant extracts, most of them showed antiviral activity against HSV-1 [33][34][35][36][37][38]. On the basis of molecular docking, some compounds present in essential oils (β-caryophyllene, caryophyllene oxide, linalool, trans-anethole, S-limonene, R-limonene, cis-verbenol, and guaiol) have been proposed as binders of SARS-CoV-2 spike and ACE2 [17]. ...
Full-text available
The COVID-19 pandemic has led to the search for new molecules with antiviral activity against SARS-CoV-2. The entry of the virus into the cell is one of the main targets for inhibiting SARS-CoV-2 infection. Natural products are an important source of new therapeutic alternatives against diseases. Pseudotyped viruses allow the study of SARS-CoV-2 viral entry inhibitors, and due to their simplicity, they allow the screening of a large number of antiviral candidates in Biosafety Level 2 facilities. We used pseudotyped HIV-1 with the D614G SARS-CoV-2 spike glycoprotein to test its ability to infect ACE2-expressing HEK 293T cells in the presence of diverse natural products, including 21 plant extracts, 7 essential oils, and 13 compounds from plants and fungi. The 50% cytotoxic concentration (CC50) was evaluated using the resazurin method. From these analyses, we determined the inhibitory activity of the extract of Stachytarpheta cayennensis, which had a half-maximal inhibitory concentration (IC50) of 91.65 µg/mL, a CC50 of 693.5 µg/mL, and a selectivity index (SI) of 7.57, indicating its potential use as an inhibitor of SARS-CoV-2 entry. Moreover, our work indicates the usefulness of the pseudotyped-virus system in the screening of SARS-CoV-2 entry inhibitors.
Natural products, along with food, clothes, and shelter, serve as the basis of treatment since the dawn of human civilization; while the modern medicine has developed over the years by observational and scientific efforts from ancient traditions. Impressive array of bioactivities with minimum or no toxicity was reported with diverse botanicals against several chronic and difficult-to-treat diseases when most synthetic drugs showed unacceptable side effects. A whole range of viral diseases including Dengue, Ebola, drug-resistant Herpes, HIV/AIDS, Japanese Encephalitis, Rabies, SARS, and recent pandemic of SARS Coronavirus-2 need effective prophylactic or therapeutic agents. Considerable research carried out for last few decades on the Pharmacognosy, chemistry; pharmacology and therapeutics of traditionally used medicines of diverse cultures forced most pharmaceutical companies to renew their strategies of drug discovery, from ‘synthetic to green chemistry’, against different stages of virus infection cycle or host-virus interaction where no effective vaccine or drugs exist. Thus, plants or phytochemicals having potentials of preventing or inhibiting viral infection cycle need to studied in-depth with the purity, safely and potency including their standardization, isolation, efficacy, mechanism of action, along with adverse effect on the host to reduce the time and cost of drug discovery. This updated review will portray the in-depth scientific knowledge and steps for the development of nature-based solutions against genetically and functionally diverse viral diseases from age-old traditional medicines.
Purpose of study The undertaken study aims to assess the polyphenolic profile, and antioxidant, antimicrobial, antiviral, antidiabetic, and cytotoxic potential of Seriphidium kurramense (Qazilb.) Y. R. Ling extracts. Methods Extracts of aerial parts were prepared by successive extraction (n-hexane {Sk-nH}, ethyl acetate {Sk-EA}, methanol {Sk-M} and aqueous {Sk-Aq}). Chromogenic assays determined the antioxidant profile while HPLC quantified several polyphenols. Agar well diffusion was employed for antimicrobial potential while brine shrimp and hemolytic assays established the biosafety profile. Results The results have shown that maximum extract recovery (17.49% w/w), total phenolics content (24.44 ± 0.15 μg GAE/mgE), and total flavonoids content (6.87 ± 0.25 μg QE/mgE) were recorded in Sk-Aq. RP-HPLC quantified a significant amount of syringic acid (1.43 ± 0.05 µg/mgE), caffeic acid (0.48 ± 0.02 µg/mgE), gentisic acid (6.44 ± 0.01 µg/mgE), and quercetin (4.39 ± 0.01 µg/mgE) in Sk-Aq, while maximum amounts of thymoquinone (0.21 ± 0.02 µg/mgE) and luteolin (3.90 ± 0.03 µg/mgE) along with apigenin (3.72 ± 0.03 µg/mgE) existed in Sk-M and highest quantities of ferulic acid (2.98 ± 0.01 µg/mgE), myricetin (1.04 ± 0.02 µg/mgE) and kaempferol (1.23 ± 0.01 µg/mgE) were found to be present in Sk-EA. A substantial free radical scavenging (85.87 ± 1.00%), total reducing power (211.93 ± 0.97 µg AAE/mgE), and urease inhibition activity (87.99 ± 0.19% at 500 µg/ml) were also recorded in the Sk-Aq. The highest antioxidant capacity (243.5 ± 1.12 µg AAE/mgE), antibacterial, antifungal, and antiviral activity (100% reduction in plaque formation at 400 µg/ml) were observed for Sk-EA. Maximum antibacterial and antifungal activities were revealed against Klebsiella pneumoniae (MIC= 25 ± 0.37 µg/ml), and Candida albicans (MIC= 50 ± 0.19 µg/ml) respectively. The prominent antidiabetic potential was displayed by Sk-nH in terms of α-amylase and α-glucosidase inhibition. Conclusion The results reported, herein suggest that S. kurramense can be a promising candidate for antioxidant, antibacterial, antifungal, antiviral, and antidiabetic secondary metabolites.
Despite more than 400 species of Baccharis occurring worldwide, only less than 20% of the species have chemically been studied. In the Baccharis genus, within terpenes and other phenolic compounds (see Chaps. 12 and 13), flavonoids are largely accumulated as aglycone, being apigenin, genkwanin, hispidulin, kaempferol (flavones), quercetin (flavonol), naringenin, sakuranetin (flavanones), and others widely distributed. Additionally, some flavonoid glycosides such as quercitrin, rutin, and others are also found, but in minor frequency. Flavonoids are compounds with a basic skeleton of 15 carbons (C6-C3-C6) arranged in two aromatic rings linked through a three-carbon moiety. The oxidation degree of the C3 moiety is directly related to the classification of flavonoids into flavanones, flavones, isoflavones, flavanonols, and flavonols. With respect to biological activity, flavonoids from Baccharis display a significant antioxidant potential, especially for the capacity of suppression of ROS formation, ROS scavenging, and upregulation of antioxidant defenses. In this chapter, the distribution of flavonoids in Baccharis is so justified through this antioxidant effect since those species are inserted in areas with direct incidence of sunrays, such as in montane savannas. In addition, flavonoids display hepatoprotective, antimicrobial, anti-inflammatory, antitumoral, antiviral, and other activities. In this chapter, the occurrence and distribution of flavonoids in Baccharis species are discussed, as well as their biosynthesis and biological aspects.
The recent outbreak of coronavirus disease 2019 (COVID-19) is a respiratory infection and it can spread from animal to person, person to person through coughing or physical contact. Recent studies revealed that the genome sequence of this pandemic disease is very similar to that of SARS-CoV, thus, there are not yet effective treatments that target the 2019-nCoV virus. Medicinal plants present a potential solution to resolve the drug problem. In fact, the bioactive compounds such as phenols, flavonoids, monoterpenes, and phenylpropanoids, derived from several herbs such as Eucalyptus globulus, Mentha spicata, Nigella sativa, Rosmarinus officinalis, Thymus capitatus and Zingiber officinale could be used to develop formal drugs against several diseases with no or minimal side effects. In this paper, we describe the potential antiviral properties of several medicinal plants against Coronaviridae family viruses such as SARS, MERS, and IBV. Besides, we review various species of medicinal herbs and their derived phytochemical compounds in terms of their immunomodulatory bioactivities and antiviral activity.
Plants are a fascinating group of plants that have been dominating the earth for 400 million years. During evolution, they have undergone series of evolutionary changes to suit themselves with the surrounding environment. These evolutionary changes not only included morphological changes to suit varied climatic conditions but also armed with intricate physiological changes to synchronize with the former and fortify better adaptability. These physiological changes of the plant later proved to be of immense help to the humans who evolved much later somewhere between 6 million to 2 million years ago. The physiological and biochemical evolution of the plants with the synchronous origin of various taxa resulted in the formation of numerous biochemical pathways producing a large number of secondary metabolites whose one primary aim is to protect the plants from herbivores and insect which in the due course of evolution became an integral part of the food chain. However, the secondary metabolites also proved to be of immense use to humans since antiquity who unknowingly since prehistoric times used plants for their food and medicine. It is only in the past hundred years or so, people became aware of the chemical constituent of the plants and started exploring their various beneficial properties. The agricultural activities also coevolved with human civilization and with the increase in population, higher yield along with protection of crops from pathogen attack became a necessity. This lead to the formulation of fertilizers which consequently paved the way for biofertilizers with a fewer side effects on humans and animals but with a more green approach towards fertility enhancement. With the advent of industrialization the menace of pollution cropped up and presently this pollution is encroaching soil water and air. This is having a deleterious effect on the ecosystem concerning human and animal health and also agricultural productivity. Thus keeping this in mind the scientific community was determined to remediate the polluted sites with the help of biological agents in which the plants and microbes played an important role. This provided major protection to agriculture from contamination thereby sustaining productivity. Thus, an attempt is made to highlight the progress and advances in the field of agriculture and plant science. Thus A handbook of Agricultural and Plant Sciences is an attempt to compile information related to the field of agriculture and plant science. The main purpose of the book is to provide relevant information to the readers on aspects largely cantered on plants. The book is divided into three sections namely agriculture and sustainable development, plants and microbes as nutraceutical agents, and medicinal potential of plants. Selected chapters in relevance to the sections have been accommodated to provide an overview. The first section deals with various aspects through which crops can be fortified through bio fertilization and also decontamination of polluted lands. The world population is presently stressing upon consumption of foods from natural sources as consumption of fast food with artificial agents is leading to the onset of several diseases. This has led to a group of foods that confers nutrition as well as a medicinal benefit at the same time. They are presently termed and considered nutraceuticals. The second section of the book deals with the nutraceutical potential of plants and microbes which are symbiotically associated with plants. The third section is also related to the second one concerning the medicinal importance. This section encompasses the medicinal importance of plants. Plants as antiviral agents have been accommodated because of the current pandemic situation. The section also contains a chapter on the ant diabetic potential of plants and also the medicinal importance of gymnosperms and bioactive potentials of bryophytes which adds up to the variation in chapters focusing on the medicinal aspect. The book is also accompanied by several tables within each chapter which gives a clear and systematic description of the theme that is discussed upon. The book is an academic venture and would benefit the scientific community and readers who are interested in the field of plant sciences.
Full-text available
Ethnopharmacological relevance: Eclipta alba, traditionally known as bhringraj, has been used in Ayurvedic medicine for more than 1000 years in India. It is used for the treatment of infective hepatitis, liver cirrhosis, liver enlargement and other ailments of liver and gall bladder in India. The aim of this study was to evaluate anti-hepatitis C virus activity present in the Eclipta alba extract, perform bioassay based fractionation and identify anti-HCV phytochemicals from the active fractions. Materials and methods: Identification of active compounds was performed by bio-activity guided fractionation approach. Active isolates were separated by the combination of silica gel chromatography and preparative scale reverse phase HPLC. Eclipta alba extract and its isolates were examined for their ability to inhibit HCV replicase (HCV NS5B) activity in vitro and HCV replication in a cell culture system carrying replicating HCV subgenomic RNA replicon. The purified isolates were also examined for their binding affinity to HCV replicase by fluorescence quenching and their cytotoxicity by MTT assay. Results: Eclipta alba extract strongly inhibited RNA dependent RNA polymerase (RdRp) activity of HCV replicase in vitro. In cell culture system, it effectively inhibited HCV replication which resulted in reduced HCV RNA titer and translation level of viral proteins. Bioassay-based fractionations of the extracts and purification of anti-HCV phytochemicals present in the active fractions have identified three compounds, wedelolactone, luteolin, and apigenin. These compounds exhibited dose dependent inhibition of HCV replicase in vitro, and anti-HCV replication activity in the cell culture system Conclusion: Eclipta alba extract and phytochemicals isolated from active fractions display anti-HCV activity in vitro and in cell culture system. The standardized Eclipta alba extract or its isolates can be used as an effective alternative and complementary treatment against HCV.
The methanol spectra of flavones and flavonols exhibit two major absorption peaks in the region 240 – 400 nm¹. These two peaks are commonly referred to as Band I (usually 300 – 380 nm, Table V-1 records the λmaxvalues for Band I for all flavones and flavonols examined in the present investigation), and Band II (usually 240 – 280 nm). Band I is considered to be associated with absorption due to the B-ring cinnamoyl system, and Band II with absorption involving the A-ring benzoyl system (see III) [1].
The bioassay of T. minuta and S. areira oils and their pure principal components revealed strong inhibitory activity of the root growth of Zea mays seedlings. Both T. minuta and S. areira oils treatment presented an increase in malondialdehyde values from 24 to 48 h, while the main components of the essential oils, ocimenone, alpha-pinene and limonene, presented an increase from 24 to 96 h indicating lipid peroxidation. The T. minuta essential oil had a greater inhibitory action and oxidant effect on the root of Zea mays than S. areira oil.
Herpes simplex virus type-1 (HSV-1) is among the most common human pathogens worldwide. Its entry into host cells is an intricate process that relies heavily on the ability of the viral glycoproteins to bind host cellular proteins and to efficiently mediate fusion of the virus envelope with the cell membrane. Acquisition of HSV-1 results in a lifelong latent infection. Because of the cycles of reactivation from a latent state, much emphasis has been placed on the management of infection through the use of DNA synthesis inhibitors. However, new methods are needed to provide more effective treatment at earlier phases of the viral infection and to prevent the development of drug resistance by the virus. This review outlines the infection process and the common therapeutics currently used against the fundamental stages of HSV-1 replication and fusion. The remainder of this article will focus on a new approach for HSV-1 infection control and management, the concept of glycoprotein-receptor targeting. Copyright © 2013 John Wiley & Sons, Ltd.
From a panel of 22 flavonoids, we identified six compounds (apigenin, baicalein, biochanin A, kaempferol, luteolin, naringenin) that inhibited influenza A nucleoprotein production in human lung epithelial (A549) cells infected with the highly pathogenic avian influenza H5N1 virus strain A/Thailand/Kan-1/04 in non-toxic concentrations. Baicalein (IC(50): 18.79±1.17μM, selectivity index 5.82) and biochanin A (IC(50) 8.92±1.87μM, selectivity index 5.60) were selected for further experiments. Both compounds reduced H5N1 infectious titres (baicalein 40μM: 29-fold reduction, biochanin A 40μM: 55-fold reduction after infection at MOI 0.01), virus-induced caspase 3 cleavage, nuclear export of viral RNP complexes, and enhanced the effects of the neuraminidase inhibitor zanamivir. Biochanin A and baicalein also inhibited the replication of the H5N1 strain A/Vietnam/1203/04. Time of addition experiments indicated that both compounds interfere with H5N1 replication after the adsorption period. Further mechanistic investigations revealed clear differences between these two flavonoids. Only baicalein interfered with the viral neuraminidase activity (39±7% inhibition at 100μM, the maximum concentration tested). In contrast to baicalein, biochanin A affected cellular signalling pathways resulting in reduced virus-induced activation of AKT, ERK 1/2, and NF-kB. Moreover, biochanin inhibited the virus-induced production of IL-6, IL-8, and IP-10 while baicalein inhibited IL-6 and IL-8 production without affecting IP-10 levels. In primary human monocyte-derived macrophages, only baicalein but not biochanin A impaired H5N1 virus replication. Both flavonoids interfered with the H5N1-induced production of IL-6, IP-10, and TNF-α but not of IL-8 in macrophages. These findings indicate that closely related flavonoids can exert anti-H5N1 effects by different molecular mechanisms.